Clinical trial
Quantitative Prostate Cancer Contrast-enhanced Ultrasound
NCT02295449 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantitative Prostate Cancer Contrast-enhanced Ultrasound
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 9, 2015
- Completion date
- June 30, 2020
- Enrollment
- 130 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer